Sunway Healthcare’s 2Q26 earnings jump

By the Editorial Team · Friday, August 21, 2026

Sunway Healthcare Holdings Bhd nearly doubled its net profit to RM78.16 million in Q2 2026, driven by strong hospital performance and increased foreign patient revenue. The group plans to sustain growth by expanding its patient base and managing costs amid ongoing geopolitical uncertainties affecting the region.

Sunway Healthcare Holdings Bhd reported significant growth in its financial results for the second quarter of the 2026 fiscal year, driven by strong performance across its hospital network and increased contributions from newer facilities. The Malaysian healthcare group recorded a net profit of RM78.16 million for the quarter ended June 30, 2026, nearly doubling the RM41.39 million reported in the same period last year. For the first half of the year, cumulative earnings rose to RM111.49 million from RM80.14 million in the corresponding period of 2025.

Revenue for the second quarter reached RM672.9 million, up from RM518.58 million a year earlier, supported by accelerated contributions from all hospitals following a slower first quarter. Half-year revenue expanded to RM1.26 billion compared to RM992.62 million in the first half of 2025.

Sunway Medical Centre (SMC) Sunway City remained the group’s primary source of revenue and profit, while more established hospitals such as SMC Velocity and SMC Penang benefited from higher patient volumes and improved revenue per patient. The group’s newer hospitals, SMC Damansara and SMC Ipoh, continued to gain traction, with their combined revenue share increasing to 11% of total revenues, compared with 5% in 2025. Both are now contributing positively to earnings before interest, taxes, depreciation, and amortisation (EBITDA).

Foreign patient revenue, a key growth driver, rose 31% year-on-year, largely due to increased patient inflows from Indonesia, China, and Cambodia. Local patient revenue also grew by 30% over the same period. The group expanded its total licensed bed capacity by 13% to 1,855 beds, and as of June 30, 2026, total bed capacity stood at 2,072 beds, providing room for further growth. Bed occupancy rates improved to 73%, up from 67% the previous year, as inpatient admissions climbed 19% to 32,599.

Looking ahead to the second half of 2026, Sunway Healthcare expressed confidence in sustaining its earnings momentum with a more balanced contribution from across its portfolio. The group acknowledged that ongoing geopolitical uncertainties could continue to affect regional travel, freight, and input costs. However, it maintained that demand for private healthcare and medical tourism remained robust.

To support future growth, the group plans to diversify its foreign patient source markets and referral channels, while continuing to manage costs prudently. It also aims to maintain adequate inventory levels and strengthen partnerships to mitigate potential supply chain disruptions.

This article was reported by synthesizing coverage from multiple independent news outlets to present a balanced, unbiased account. Read about our editorial standards. Spotted an error? Let us know.